Gentaur Donanemab – Anti-APP Antibody

https://www.pathco.org/web/image/product.template/137746/image_1920?unique=6dd64d0
(0 review)
Targets amyloid precursor protein (APP), used in Alzheimer’s disease research, amyloid clearance, and neurodegeneration assays.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.


Internal Reference: GMA-APP
Display Name: [GMA-APP] Gentaur Donanemab – Anti-APP Antibody
Image 512: